Key issues unsettled in Mercosur talks

The Israel-Latin America Chamber of Commerce will hold a seminar on trading with Mercosur this Thursday evening at the Sheraton Hotel in Tel Aviv.

By DANIEL KENNEMER
June 7, 2006 09:40

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A third round of talks between Israel and the South American trade block Mercosur has ended without agreement on key issues related to Israeli exporters' access to South American markets and the reduction of import tariffs, the Industry, Trade and Labor Ministry said Tuesday. "Understandings in principle" on the matters, however, were reached, the ministry noted, indicating that progress was achieved on conflict resolution protocols, origin rules, and means of protection. The Israel-Latin America Chamber of Commerce will hold a seminar on trading with Mercosur this Thursday evening at the Sheraton Hotel in Tel Aviv.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS